Host Immune System Gene Targeting by a Viral miRNA
By Noam Stern-Ginossar, Naama Elefant, A. Zimmermann, D. Wolf, Nivin Saleh, Moshe Biton, Elad Horwitz, Zafnat Prokocimer, M. Prichard, G. Hahn and 7 more. Science, 2007
701 citations recorded by the source corpus.
Subfields: Epidemiology, Immunology, Molecular Biology
View Paper: https://www.semanticscholar.org/paper/ef89ff1f56bf8496b58c5107c8c4d246a8313839
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Epidemiology
In Immunology
- Ryan M. O’Connell
- S. Gasser
- W. Deng
- David Baltimore
- Heiyoun Jung
- Benjamin G. Gowen
- D. Rao
- Shou-Wei Ding
In Molecular Biology
- David Baltimore
- Ryan M. O’Connell
- D. Rao
- Aadel A Chaudhuri
- Shou-Wei Ding
- Olivier Voinnet
- Rebecca L. Skalsky
- Changchun Xiao
Citations in the corpus
- Regulation of ligands for the NKG2D activating receptor (2013, background): “The initial relevant findings were that the human cytomegalovirus (84) as well as other viruses (85, 86) encode microRNAs that downregulate the expression of MICA, MICB, or ULBP3.”
- MicroRNA control in the immune system: basic principles. (2009, background): “Thus, miR-UL112 encoded by human cytomegalovirus (HCMV) downregulates the expression of major histocompatibility complex class I-related chain B (MICB), a stress-induced ligand of the natural killer (NK) cell activating receptor (NKG2D) that is critical for the NK cell killing of virus-infected cell”
- Characterization of extracellular circulating microRNA (2011, background): “The recent discovery of virally encoded miRNAs in several pathogenic human viruses suggests that miRNAs may function in interspecies regulation involving viral miRNAs and host genes (21,22).”
- Antiviral immunity directed by small RNAs. (2007, positive): “Several additional studies support the view that vertebrate viruses might extensively usurp the host miRNA pathway to complete their infection cycle (Jopling et al., 2005; Stern-Ginossar et al., 2007).”
- Revisiting the principles of microRNA target recognition and mode of action (2009, background): “In human cells, cytomegalovirus produces a miRNA that uses a non-seed target site to repress a major histocompatibility complex-related gene, thereby avoiding the destruction of infected cells by the host immune syste”
- Physiological and pathological roles for microRNAs in the immune system (2010, background): “It is interesting to note that certain herpesvirus family members, namely cytomegalovirus, Epstein–Barr virus and Kaposi's sarcoma-associated herpesvirus (KSHV), produce miRNAs that target MICB mRNA, and this has been proposed as a mechanism of immune evasion by these viruse”
- Viruses, microRNAs, and Host Interactions (2010, background): “Viral miRNA-mediated MICB downregulation leads to a reduction in NK-cell-mediated killing of infected cells (66, 84).”
- The Role of MicroRNAs in Human Diseases (2010, background): “For example, miR-UL112-1 expressed by the human cyto-megalovirus has been demonstrated to target the major histocompatibility complex class 1-related chain B (162) .”
- Immunobiology of Human Cytomegalovirus: from Bench to Bedside (2009, background): “(259), inhibition of NK cell-mediated lysis by HCMV UL142”
- Functional delivery of viral miRNAs via exosomes (2010, background): “Virus-encoded miRNAs may exploit the host miRNAmachinery as part of a viral strategy to avoid host immune responses by silencing endogenous immunoregulatory genes (26), as recently shown in EBV lymphomas where the EBV-miRNA BHRF1-3 (15) targets the immunostimulatory gene CXCL11 (11).”
- Modulation of natural killer cell activity by viruses (2010, positive): “Very recently crystal structure of UL16 in complex with MICB revealed that UL16 mimics a central binding motif of otherwise structurally unrelated NKG2D thus enabling the virus to disable several diverse NKG2D ligands [30].”